SONOMA PHARMACEUTICALS INC (SNOA) Stock Analyst Earnings Estimates
NASDAQ:SNOA - Nasdaq - US83558L3033 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 12.63M -32.21% | 13.27M 5.07% | 12.735M -4.03% | 15.778M 23.89% | 19.794M 25.45% | |
| EBITDA YoY % growth | -5.48M -82.67% | -4.2M 23.36% | -4.525M -7.74% | N/A | N/A | |
| EBIT YoY % growth | -5.67M -75.54% | -4.33M 23.63% | -4.701M -8.57% | -4.09M 12.99% | -3.029M 25.94% | |
| Operating Margin | -44.89% | -32.63% | -36.91% | -25.92% | -15.30% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.68 24.72% | -1.82 -166.72% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.74 -329.41% | -0.63 55.05% | -0.37 36.55% | -0.40 37.02% | -0.44 41.10% |
| Revenue Q2Q % growth | 4.529M 31.70% | 4.428M 30.58% | 4.605M 28.67% | 5.117M 43.57% | 5.644M 24.62% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.081M 23.26% | -969K 17.39% | -591.6K 30.40% | -673.2K 34.70% | -795.6K 26.42% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.63 60.63% | -0.70 | 0.07 | 10.49% |
| Q2 2025 Q2Q % growth | -0.59 89.83% | -1.02 | 0.43 | 42.16% |
| Q1 2025 Q2Q % growth | -1.40 | -1.22 | -0.18 | -14.38% |
| Q3 2024 Q2Q % growth | -1.60 | -4.28 | 2.68 | 62.65% |
| Q2 2024 Q2Q % growth | -5.80 -1,657.58% | -4.90 | -0.90 | -18.46% |
| Q2 2023 Q2Q % growth | -0.33 -725.00% | % | ||
| Q1 2023 Q2Q % growth | -0.29 44.23% | % | ||
| Q3 2022 Q2Q % growth | -0.31 3.13% | % | ||
| Q2 2022 Q2Q % growth | -0.04 -166.67% | % | ||
| Q1 2022 Q2Q % growth | -0.52 -196.30% | % | ||
| Q4 2021 Q2Q % growth | -1.76 -126.86% | % | ||
| Q2 2021 Q2Q % growth | 0.06 100.33% | % | ||
| Q1 2021 Q2Q % growth | 0.54 -95.00% | % | ||
| Q4 2020 Q2Q % growth | -0.77 97.45% | % | ||
| Q2 2020 Q2Q % growth | -18.20 77.02% | -24.07 | 5.87 | 24.39% |
| Q1 2020 Q2Q % growth | 10.80 110.91% | -36.52 | 47.32 | 129.58% |
| Q4 2019 Q2Q % growth | -30.40 | -43.35 | 12.95 | 29.87% |
| Q3 2019 Q2Q % growth | -46.80 | -61.51 | 14.71 | 23.91% |
| Q2 2019 Q2Q % growth | -79.20 | -83.54 | 4.34 | 5.19% |
| Q1 2019 Q2Q % growth | -99.00 | -84.46 | -14.54 | -17.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 3.564M 13.58% | 4.141M | -577K | -13.93% |
| Q2 2025 Q2Q % growth | 3.579M 31.05% | 4.06M | -481K | -11.85% |
| Q1 2025 Q2Q % growth | 3.391M -1.14% | 4.019M | -628K | -15.63% |
| Q4 2024 Q2Q % growth | 3.439M 14.25% | 4.06M | -621K | -15.30% |
| Q3 2024 Q2Q % growth | 3.138M 6.73% | 3.835M | -697K | -18.17% |
| Q2 2024 Q2Q % growth | 2.731M -17.99% | 3.55M | -819K | -23.07% |
| Q1 2024 Q2Q % growth | 3.43M -13.82% | % | ||
| Q4 2023 Q2Q % growth | 3.01M 30.87% | % | ||
| Q3 2023 Q2Q % growth | 2.94M 1.38% | % | ||
| Q2 2023 Q2Q % growth | 3.33M -10.96% | % | ||
| Q1 2023 Q2Q % growth | 3.98M 8.15% | % | ||
| Q4 2022 Q2Q % growth | 2.3M 6.48% | % | ||
| Q3 2022 Q2Q % growth | 2.9M -41.30% | % | ||
| Q2 2022 Q2Q % growth | 3.74M -35.18% | % | ||
| Q1 2022 Q2Q % growth | 3.68M -36.22% | % | ||
| Q4 2021 Q2Q % growth | 2.16M -49.88% | % | ||
| Q3 2021 Q2Q % growth | 4.94M 12.27% | % | ||
| Q2 2021 Q2Q % growth | 5.77M 21.99% | % | ||
| Q1 2021 Q2Q % growth | 5.77M 28.51% | % | ||
| Q4 2020 Q2Q % growth | 4.31M -1.60% | % | ||
| Q3 2020 Q2Q % growth | 4.4M -16.67% | % | ||
| Q2 2020 Q2Q % growth | 4.73M -4.25% | 4.794M | -64K | -1.34% |
| Q1 2020 Q2Q % growth | 4.49M 2.75% | 4.794M | -304K | -6.34% |
| Q4 2019 Q2Q % growth | 4.38M | 5.212M | -832K | -15.96% |
| Q3 2019 Q2Q % growth | 5.28M | 5.269M | 11K | 0.21% |
| Q2 2019 Q2Q % growth | 4.94M | 4.872M | 68K | 1.40% |
| Q1 2019 Q2Q % growth | 4.37M | 4.291M | 79K | 1.84% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -812.5% | 0% | 83.25% |
| Revenue | 0% | -8.63% | 0% | -8.9% |